An outreach activity brings photopharmacology closer to students in Barcelona
PHOTOTHERAPORT researchers from the Institute of Biomedical Research of Barcelona (IIBB-CSIC) and the Institute of Bioengineering of Catalonia (IBEC) participated […]
PHOTOTHERAPORT researchers from the Institute of Biomedical Research of Barcelona (IIBB-CSIC) and the Institute of Bioengineering of Catalonia (IBEC) participated […]
PHOTOTHERAPORT researchers Pau Gorostiza and Rossella Castagna recently took part in different events aimed to help new EIC Pathfinder proposals
On 14 February, Bia Moreno, the communication officer for PHOTOTHERAPORT at the Institute of Bioengineering of Catalonia (IBEC), visited a
A recent study led by PHOTOTHERAPORT researcher Valerija Groma at Riga Stradins University, has unveiled pivotal connections among joint inflammation,
On 27 September 2024, researchers from all over Europe took part in the European Researchers’ Night. Among them, Rossella Castagna,
Researchers from PHOTOTHERAPORT Project have developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. These compounds, which
The Youth and Science program from Catalunya La Pedrera Foundation in Barcelona puts together 15–16-year-old students with scientists from different
The 17th Science Party (“Festa de la Ciència” in Catalan) took place last 7th – 9th of June in Barcelona, and researchers from the Institute for Bioengineering of Catalonia (IBEC) and the Institute of Biomedical research from Barcelona (IIBB-CSIC) proposed a series of hands-on activities to explain PHOTOTHERAPORT project to a non-specialized public and to bring photopharmacology closer to the society.
Valērija Groma, principal investigator of PHOTOTHERAPORT at Riga Stradins University (RSU) in Latvia, together with several members of her team, hosted a group of students during the “Shadow day”.
Students of the Secondary School Angeleta Ferrer in Barcelona had the occasion to know the PHOTOTHERAPORT project and learn about light-emitting implants and light-controlled drugs.